   
Mega power in
antibiotic therapy...
Cefpodoxim Proxitil 100/200/Susp
|
 |
 100%
Sensitivity |
Low
MIC Advantage |
97.2%
Clinical Efficacy |
| Against Salmonella and Shigella strains |
Lower MIC values against various pathogens |
In pneumonia and URTI |
|
Ideal Oral Follow up |
In Acute Otitis
Media |
| Matches
Ceftriaxone in terms of
1. Kill Power 2. Expanded Coverage |
The only
Cephalosporin approved by USFDA for 5 day therepy course
The annals of Pharmacotherapy, 1995 June, Vol. 29:561-565 |
| |
|
|
In Typhoid Fever |
In Pneumonia |
|
100 % sensitivity against multidrug resistant Salmonella typhi reported
with Cefpodoxime JPMA Vol 49, No. 6
June 1999 |
Exhibits 97.2% clinical efficacy in pneumonia & URTI. jpn.
J Antibiot 1999,52:553-540 |
|
